Rubicon Research Limited (BOM:544578)
India · Delayed Price · Currency is INR 1,004.00
+38.20 (3.96%)
At close: May 29, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 165.67 billion as of June 1, 2026.
Market Cap
165.67B
Enterprise Value
165.17B
Revenue
17.62B
Ranking
n/a
PE Ratio
67.15
Stock Price
1,004.00
Market Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 165.67B, an increase of 60.08%. That is a compound annual growth rate of 114.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 165.67B | 47.72% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 374.17B |
| J. B. Chemicals & Pharmaceuticals | 348.81B |
| AstraZeneca Pharma India | 216.79B |
| Granules India | 191.37B |
| Rubicon Research | 165.67B |
| Jubilant Pharmova | 157.38B |
| Caplin Point Laboratories | 154.31B |
| Viyash Scientific | 113.07B |